MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-18-0028286
Market Cap
₹90.42 Cr
AAKAAR-SM · NSE
Share Price
₹63.65
-0.24% today
Revenue
₹66.96 Cr
FY 2025-26 · +8.7% YoY
EBITDA
₹10.31 Cr
Margin 15.4%
Net Profit
₹6.62 Cr
FY 2025-26 · +9.6% YoY
P/E (TTM)
13.6x
P/B 1.7x
ROE
17.1%
ROCE 18.2%
Debt / Equity
0.53
Interest cover 17.7x
About Aakaar Medical Technologies Limited
Data last updated:
Aakaar Medical Technologies Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the health and beauty retail and distribution segment of the consumer goods sector. It was incorporated on 20 June 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN L74900MH2013PLC244717. Its GSTIN is 27AALCA7587Q1ZK (Maharashtra). The company holds 2 GST registrations, of which 1 is active. It is a listed company as per MCA records. Its shares are listed on NSE: AAKAAR.
The company has an authorised share capital of ₹15.4 Cr and a paid-up capital of ₹14.17 Cr. It is led by directors including Dilip Ramesh Meswani (Managing Director) and Bindi Dilip Meswani.
Its last annual general meeting (AGM) was held on 30 June 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at 801 Heritage Plaza Telli Galli Cross Road Andheri (East), Mumbai, Maharashtra, India – 400069.
As per the latest standalone financials for FY 2025-26, the company reported a revenue of ₹66.96 Cr, a growth of 8.7% compared to the previous year. For the same year it recorded a net profit of ₹6.62 Cr (net margin 9.9%) and EBITDA of ₹10.31 Cr (EBITDA margin 15.4%). The net worth stands at ₹54.55 Cr (up 134.5% YoY). Total assets are valued at ₹74.07 Cr (up 57.8% YoY).
The company has about 103 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Aakaar Medical Technologies. As per MCA filings, the company has open charges of ₹22 Cr and satisfied charges of ₹5 Cr on record. Court records list 2 cases involving the company, including 2 filed by the company; 1 case is pending. The company has 6 deals on record (3 secondary share transfers, 1 rights issue, 1 funding round), with disclosed funding of ₹4.75 Cr; the latest was in June 2025.
Aakaar Medical Technologies Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0028286). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website aakaarmedical.in.
Company details
CIN L74900MH2013PLC244717
Registration Number 244717
Incorporation Date 20 June 2013
ROC Mumbai
Listing Status Listed (NSE: AAKAAR)
Company Status Active
Date of Last AGM 30 June 2026
Date of Balance Sheet 31 March 2026
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-18-0028286
CIN history
Aakaar Medical Technologies has one previous CIN (Corporate Identification Number): U74900MH2013PTC244717. The current CIN is L74900MH2013PLC244717, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L74900MH2013PLC244717 | Current |
| U74900MH2013PTC244717 | Previous |
Key People
Dilip Ramesh Meswani Managing Director Bindi Dilip Meswani Director Rajendra Indubhai Dhandhukia Director Recognitions & Rankings of Aakaar Medical Technologies
Contact details
Aakaar Medical Technologies Limited's registered office is in Mumbai, Maharashtra. Its website is aakaarmedical.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address801 Heritage Plaza Telli Galli Cross Road Andheri (East), Mumbai, Maharashtra, India – 400069
- IndustryConsumer Goods, Health & Beauty Retail & Distribution
To see the full contact details of Aakaar Medical Technologies Limited, buy the company report.
Comprehensive company report
Aakaar Medical Technologies Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Aakaar Medical Technologies operates one associated brand: Aakaar Medical Technologies. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Skin care products and devices are manufactured for healthier skin. | aakaarmedical.in |
Financials of Aakaar Medical Technologies Limited
FY 2025-26 filings availableAakaar Medical Technologies Limited reported revenue of ₹66.96 Cr (up 8.7% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · StandaloneRevenue
₹66.96 Cr
+8.7% YoY
EBITDA
₹10.31 Cr
+5.5% YoY
Profit After Tax
₹6.62 Cr
+9.6% YoY
Net Worth
₹54.55 Cr
+134.5% YoY
Total Assets
₹74.07 Cr
+57.8% YoY
Total Debt
₹18.53 Cr
-18.5% YoY
Revenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 66.96 | 61.58 | 46.11 | 32.78 | 19.47 | 12.44 | 22.98 |
| Revenue growth | +8.7% | +33.6% | +40.7% | +68.4% | +56.5% | -45.9% | - |
| EBITDA | 10.31 | 9.77 | 5.00 | 3.53 | 2.38 | 0.89 | 2.87 |
| EBITDA margin | +15.4% | +15.9% | +10.8% | +10.8% | +12.2% | +7.2% | +12.5% |
| Profit before tax | 9.18 | 8.12 | 3.88 | 3.10 | 2.19 | 0.75 | 2.49 |
| Net profit | 6.62 | 6.04 | 2.86 | 2.15 | 1.61 | 0.53 | 1.82 |
| Net profit margin | +9.9% | +9.8% | +6.2% | +6.6% | +8.3% | +4.3% | +7.9% |
| EPS (₹) | 4.68 | 5.79 | 41.00 | 30.76 | 23.12 | 54.44 | 182.79 |
| Balance sheet | |||||||
| Total assets | 74.07 | 46.94 | 28.43 | 16.20 | 12.37 | 11.28 | 12.73 |
| Net worth | 54.55 | 23.26 | 12.54 | 9.66 | 8.03 | 7.40 | 6.85 |
| Total debt | 18.53 | 22.74 | 15.05 | 5.87 | 3.82 | 3.88 | 5.88 |
| Cash & bank | 16.24 | 5.55 | 0.30 | 0.19 | 2.27 | 2.82 | 0.14 |
| Net working capital | 71.26 | 44.60 | 27.23 | 15.19 | 11.69 | 10.96 | 12.02 |
| Cash flow | |||||||
| Cash from operations | (8.36) | (5.41) | (8.04) | (2.93) | 0.48 | 4.31 | (0.38) |
| Cash from investing | 0.05 | (0.05) | (0.04) | (0.32) | (0.23) | 0.37 | 0.10 |
| Cash from financing | 18.80 | 10.71 | 8.19 | 1.17 | (0.81) | (2.00) | 0.28 |
Financial Statements
Figures in ₹ Cr; negatives in brackets. Updated 26 Oct 2026
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 66.96 | 61.58 | 46.11 | 32.78 | 19.47 | 12.44 | 22.98 |
| Revenue growth | +8.7% | +33.6% | +40.7% | +68.4% | +56.5% | -45.9% | - |
| Other income | 0.80 | 0.18 | 0.16 | 0.09 | 0.04 | 0.12 | 0.12 |
| Total expenses | 56.65 | 51.81 | 41.11 | 29.25 | 17.09 | 11.55 | 20.11 |
| Employee cost | 14.01 | 12.90 | 10.36 | 7.73 | 4.79 | 2.73 | 5.61 |
| EBITDA | 10.31 | 9.77 | 5.00 | 3.53 | 2.38 | 0.89 | 2.87 |
| EBITDA margin | +15.4% | +15.9% | +10.8% | +10.8% | +12.2% | +7.2% | +12.5% |
| Depreciation | 0.13 | 0.12 | 0.14 | 0.09 | 0.02 | 0.03 | 0.04 |
| Interest | 1.80 | 1.71 | 1.14 | 0.43 | 0.21 | 0.23 | 0.46 |
| Profit before tax | 9.18 | 8.12 | 3.88 | 3.10 | 2.19 | 0.75 | 2.49 |
| Tax | 2.56 | 2.08 | 1.02 | 0.95 | 0.58 | 0.22 | 0.67 |
| Net profit | 6.62 | 6.04 | 2.86 | 2.15 | 1.61 | 0.53 | 1.82 |
| Net profit margin | +9.9% | +9.8% | +6.2% | +6.6% | +8.3% | +4.3% | +7.9% |
| EPS (₹) | 4.68 | 5.79 | 41.00 | 30.76 | 23.12 | 54.44 | 182.79 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 14.17 | 10.42 | 0.70 | 0.70 | 0.70 | 0.10 | 0.10 |
| Reserves & surplus | 40.38 | 12.84 | 11.84 | 8.96 | 7.33 | 7.30 | 6.75 |
| Shareholders' funds (net worth) | 54.55 | 23.26 | 12.54 | 9.66 | 8.03 | 7.40 | 6.85 |
| Secured loans | 18.53 | 20.19 | 9.96 | 1.07 | 2.00 | 2.00 | 4.27 |
| Unsecured loans | 0.00 | 2.55 | 5.09 | 4.80 | 1.82 | 1.88 | 1.61 |
| Total debt | 18.53 | 22.74 | 15.05 | 5.87 | 3.82 | 3.88 | 5.88 |
| Total liabilities | 74.07 | 46.94 | 28.43 | 16.20 | 12.37 | 11.28 | 12.73 |
| Assets | |||||||
| Gross block | 0.75 | 0.61 | 0.52 | 0.47 | 0.43 | 0.24 | 0.23 |
| Net block | 0.29 | 0.24 | 0.28 | 0.36 | 0.21 | 0.04 | 0.06 |
| Capital work in progress | 0.40 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.11 | 0.47 |
| Inventories | 19.75 | 14.55 | 14.18 | 11.25 | 7.00 | 6.29 | 5.90 |
| Sundry debtors | 37.23 | 28.00 | 16.26 | 10.23 | 5.57 | 4.63 | 7.39 |
| Cash & bank balances | 16.24 | 5.55 | 0.30 | 0.19 | 2.27 | 2.82 | 0.14 |
| Loans & advances | 3.39 | 3.73 | 2.07 | 0.55 | 2.49 | 0.24 | 2.15 |
| Total current assets | 76.61 | 51.83 | 32.81 | 22.22 | 17.33 | 13.98 | 15.58 |
| Total current liabilities | 5.35 | 7.23 | 5.58 | 7.03 | 5.64 | 3.02 | 3.56 |
| Net working capital | 71.26 | 44.60 | 27.23 | 15.19 | 11.69 | 10.96 | 12.02 |
| Total assets | 74.07 | 46.94 | 28.43 | 16.20 | 12.37 | 11.28 | 12.73 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 5.55 | 0.30 | 0.19 | 2.27 | 2.82 | 0.14 | 0.14 |
| Net cash from operating activities | (8.36) | (5.41) | (8.04) | (2.93) | 0.48 | 4.31 | (0.38) |
| Net cash from investing activities | 0.05 | (0.05) | (0.04) | (0.32) | (0.23) | 0.37 | 0.10 |
| Net cash from financing activities | 18.80 | 10.71 | 8.19 | 1.17 | (0.81) | (2.00) | 0.28 |
| Net change in cash | 10.48 | 5.25 | 0.11 | (2.08) | (0.55) | 2.68 | 0.00 |
| Closing cash | 16.24 | 5.55 | 0.30 | 0.19 | 2.27 | 2.82 | 0.14 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +8.7% | +33.6% | +40.7% | +68.4% | +56.5% | -45.9% | - |
| EBITDA growth | +5.5% | +95.4% | +41.6% | +48.3% | +167.4% | -69.0% | - |
| PBT growth | +13.1% | +109.3% | +25.2% | +41.6% | +192.0% | -69.9% | +9997.0% |
| Net income growth | +9.6% | +111.2% | +33.0% | +33.5% | +203.8% | -70.9% | - |
| Revenue CAGR (3Y) | +26.9% | +46.8% | +54.8% | +12.6% | - | - | - |
| EBITDA CAGR (3Y) | +42.9% | +60.1% | +77.8% | +7.1% | - | - | - |
| Profitability & leverage | |||||||
| Net income margin | +9.9% | +9.8% | +6.2% | +6.6% | +8.3% | +4.3% | +7.9% |
| Return on capital employed | +18.2% | +26.1% | +22.5% | +24.7% | +20.5% | +8.3% | +23.3% |
| Return on net worth | +17.1% | +33.7% | +25.9% | +24.3% | +21.0% | +7.6% | +26.7% |
| Debt / equity | 0.53 | 1.06 | 0.94 | 0.55 | 0.50 | 0.68 | 0.86 |
| Long-term debt / equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.25 | 0.68 | 0.86 |
| Interest cover | 17.68 | 17.72 | 23.46 | 12.50 | 8.90 | 26.74 | 16.25 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 98.47 | 108.99 | 93.15 | 72.84 | 58.12 | 52.94 | 99.91 |
| Inventory turnover | 3.90 | 4.29 | 3.63 | 3.59 | 2.93 | 2.04 | 3.89 |
| Debtors turnover | 2.05 | 2.78 | 3.48 | 4.15 | 3.82 | 2.07 | 3.11 |
| EPS (₹) | 4.68 | 5.79 | 41.00 | 30.76 | 23.12 | 54.44 | 182.79 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 7.50 | 8.00 | 0.00 | 0.00 |
| Book value per share (₹) | 38.49 | 22.32 | 179.16 | 138.01 | 114.67 | 739.76 | 685.32 |
To see the full year-wise statements and ratios of Aakaar Medical Technologies Limited, buy the company report.
Board of directors of Aakaar Medical Technologies Limited
Aakaar Medical Technologies has 5 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bindi Dilip Meswani Also directs: Revigen Medicare Private Limited | Director | 20 Jun 2013 | 13 Years 4 Months | Current |
| Dilip Ramesh Meswani Also directs: Revigen Medicare Private Limited | Managing Director | 20 Jun 2013 | 13 Years 4 Months | Current |
| Rajendra Indubhai Dhandhukia | Director | 18 Dec 2024 | 1 Years 10 Months | Current |
| Deepanjan Periwal | Director | 18 Dec 2024 | 1 Years 10 Months | Current |
| Rahul Babasaheb Sawakhande | Director | 06 Jun 2024 | 2 Years 4 Months | Current |
Auditor
Aakaar Medical Technologies Limited is audited by MADHAV JOSHI & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MADHAV JOSHI & ASSOCIATES | FY 2022 | 045105 |
Shareholding
Shareholding for the quarter ended Sep 2026: promoters hold 67.00%, foreign institutional investors hold 0.00%, domestic institutional investors hold 11.20% and retail and other public shareholders hold 21.80%.
Sep 2026
QUARTER
67.00% Promoters
11.20% DII (Domestic Institutional)
21.80% Retail & Others
Promoter holding - history
Now 67.00% · Sep 2026High 67.00% · Mar 2026Low 67.00% · Mar 2026
Shareholding trend - last 6 quarters
| Sep 2026 | Jun 2026 | Mar 2026 | |
|---|---|---|---|
| Promoters | 67.00% | 67.00% | 67.00% |
| Public | 33.00% | 33.00% | 33.00% |
Charges & borrowings
Open charges
₹22 Cr
Satisfied charges
₹5 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 01 Mar 2023 | 100705993 | Others | ₹22 Cr | Open | |
| 31 Mar 2018 | 100191742 | Citi Bank N.A. | ₹5 Cr | Satisfied |
To see the full charge records of Aakaar Medical Technologies Limited, buy the company report.
Total charge records: 2 View all charges
Deals & funding
Aakaar Medical Technologies Limited has 6 deals on record (3 secondary share transfers, 1 rights issue, 1 funding round), with disclosed funding of ₹4.75 Cr; the latest was in June 2025.
Total deals
6
Secondary share transfers
3
Rights issue
1
Funding round
1
IPO
1
Disclosed funding
₹4.75 Cr
Deals on record (5 of 6)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jun 2025 | IPO | ₹27 Cr | Investors: IPO Shareholders - Aakaar Medical Technologies Limited, India Equity Fund 1, Aarth Aif Growth Fund |
| Sep 2024 | Funding round | ₹4.75 Cr | Investors: 4 individuals |
| Aug 2024 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 3 individuals |
| Jun 2024 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Jun 2020 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
To see the full deal history of Aakaar Medical Technologies Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Aakaar Medical Technologies Limited has 2 court cases on record: 2 filed by Aakaar Medical Technologies. 1 case is pending and 1 is disposed.
Total cases
2
Filed by the company
2
Pending
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 0 |
| NCLT | 1 | 0 | 1 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLT, Mumbai | Insolvency matter | Filed by the company against Yog Power Studio Pvt Ltd | Pending |
| District court, New Delhi, Delhi | Civil suit | Filed by the company against individuals | Disposed |
To see the full case history of Aakaar Medical Technologies Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aakaar Medical Technologies Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Aakaar Medical Technologies Limited has a workforce of 103 employees on its EPFO records as of Apr 03, 2024, across 1 active EPFO establishment.
Employee count
103
Active EPFO establishments
1
Employee growth
47.14%
GST
Aakaar Medical Technologies has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AALCA7587Q1ZK | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Aakaar Medical Technologies Limited, buy the company report.
Recent activity
Aakaar Medical Technologies Limited has 9 board changes on record since 2013: 5 appointments and 4 cessations. The latest: Deepanjan Periwal was appointed as Director on 18 Dec 2024.
AGM
Aakaar Medical Technologies Limited last Annual general meeting of members was held on 30 Jun 2026 as per latest MCA records.
Filing
Aakaar Medical Technologies Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Mumbai I.
Charges
A charge registered on 31 Mar 2018 via Charge ID 100191742 with Citi Bank N.A. was fully satisfied on 15 Jul 2025.
Charges
A charge with Others of Rs. 22.00 Cr registered on 01 Mar 2023 with Charge ID 100705993 was modified on 01 Jan 2025.
Appointed
Deepanjan Periwal was appointed as Director.
Appointed
Rajendra Indubhai Dhandhukia was appointed as Director.
Ceased
Rahul Babasaheb Sawakhande ceased to be Additional Director.
Ceased
Bindi Dilip Meswani ceased to be Director.
Ceased
Dilip Ramesh Meswani ceased to be Director.
Appointed
Rahul Babasaheb Sawakhande was appointed as Director.
Charges
A charge with Others amounted to Rs. 22.00 Cr with Charge ID 100705993 was registered on 01 Mar 2023.
Ceased
Abhash Dilip Meswani ceased to be Director.
4 earlier events are in the company report.
News
Frequently asked questions
Aakaar Medical Technologies is an active public limited company based in Mumbai, Maharashtra, India. The company works in health and beauty retail and distribution, within the consumer goods industry. It was incorporated on 20 June 2013 (13+ years old) and is registered under CIN L74900MH2013PLC244717. Listed on NSE: AAKAAR.
Aakaar Medical Technologies reported revenue of ₹66.96 Cr for FY 2025-26 (up 8.7% YoY) based on standalone financials.
Aakaar Medical Technologies has 5 current directors:
- Dilip Ramesh Meswani - Managing Director
- Bindi Dilip Meswani - Director
- Rajendra Indubhai Dhandhukia - Director
- Deepanjan Periwal - Director
- Rahul Babasaheb Sawakhande - Director
The latest financial statements of Aakaar Medical Technologies on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 30 June 2026. Year-wise statements from 2015 are in the company report.
The GSTIN of Aakaar Medical Technologies is 27AALCA7587Q1ZK, registered in Maharashtra. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Aakaar Medical Technologies is L74900MH2013PLC244717. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Aakaar Medical Technologies is a listed company as per MCA records. Its shares are listed on NSE (symbol: AAKAAR).
Aakaar Medical Technologies has 2 court cases on record: 2 filed by the company. 1 is pending. Most are in the district courts.
Aakaar Medical Technologies was incorporated on 20 June 2013, making it 13+ years old. It is registered with the Registrar of Companies, Mumbai.
Aakaar Medical Technologies has 6 deals on record (3 secondary share transfers, 1 rights issue, 1 funding round), with disclosed funding of ₹4.75 Cr; the latest was in June 2025.